SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Feb-24 7:55 PM View: | Arcus Biosciences, Inc. (RCUS) | 27-Feb-24 | Sale (Planned) | 23,132 | $20.10 | $464,953.00 | (1%) 1.55M to 1.53M | |
28-Feb-24 7:55 PM View: | Arcus Biosciences, Inc. (RCUS) | 26-Feb-24 | Sale (Planned) | 3,900 | $20.06 | $78,234.00 | (< 1%) 1.56M to 1.55M | |
25-Jan-24 7:40 PM View: | Arcus Biosciences, Inc. (RCUS) | 23-Jan-24 | Grant | 40,000 | -- | -- | 13% 301.48K to 341.48K | |
04-Jan-24 5:22 PM View: | Arcus Biosciences, Inc. (RCUS) | 02-Jan-24 | Sale (Planned) | 6,975 | $20.09 | $140,128.00 | (< 1%) 1.52M to 1.52M | |
20-Dec-23 4:09 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Dec-23 | Disposition | 6,259 | $18.09 | $113,225.00 | (< 1%) 1.53M to 1.52M | |
20-Dec-23 4:09 PM View: | Arcus Biosciences, Inc. (RCUS) | 18-Dec-23 | Disposition | 6,128 | $17.74 | $108,711.00 | (< 1%) 1.54M to 1.53M | |
25-Jan-23 5:50 PM View: | Arcus Biosciences, Inc. (RCUS) | 23-Jan-23 | Grant | 45,800 | -- | -- | 3% 1.5M to 1.55M | |
16-Dec-22 9:40 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Dec-22 | Sale | 4,436 | $30.75 | $136,407.00 | (< 1%) 1.44M to 1.44M | |
21-Jun-22 4:18 PM View: | Arcus Biosciences, Inc. (RCUS) | 17-Jun-22 | Sale | 2,537 | $22.12 | $56,115.90 | (< 1%) 1.43M to 1.43M | |
21-Jun-22 4:18 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Jun-22 | Sale | 2,333 | $20.72 | $48,339.80 | (< 1%) 1.44M to 1.43M | |
10-Mar-22 5:06 PM View: | Arcus Biosciences, Inc. (RCUS) | 08-Mar-22 | Grant | 31,250 | -- | -- | 2% 1.42M to 1.45M | |
02-Mar-22 5:02 PM View: | Arcus Biosciences, Inc. (RCUS) | 28-Feb-22 | Gift | 350,000 | -- | -- | (20%) 1.77M to 1.42M | |
20-Dec-21 4:19 PM View: | Arcus Biosciences, Inc. (RCUS) | 17-Dec-21 | Market Sale | 1,108 | $40.36 | $44,715.50 | (< 1%) 1.77M to 1.77M | (3%) |
20-Dec-21 4:19 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Dec-21 | Market Sale | 865 | $39.82 | $34,448.30 | (< 1%) 1.78M to 1.77M | (4%) |
21-Jun-21 4:50 PM View: | Arcus Biosciences, Inc. (RCUS) | 17-Jun-21 | Market Sale | 2,675 | $23.68 | $63,344.00 | (< 1%) 1.77M to 1.77M | 3% |
21-Jun-21 4:50 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Jun-21 | Market Sale | 2,182 | $24.16 | $52,707.30 | (< 1%) 1.78M to 1.77M | 5% |
20-Jan-21 4:12 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Jan-21 | Grant | 19,375 | -- | -- | 1% 1.76M to 1.78M | |
15-Oct-20 4:46 PM View: | Arcus Biosciences, Inc. (RCUS) | 13-Oct-20 | Gift | 1,207,000 | -- | -- | (41%) 2.97M to 1.76M | |
08-Jun-20 4:27 PM View: | Arcus Biosciences, Inc. (RCUS) | 04-Jun-20 | Grant | 55,000 | -- | -- | 2% 2.97M to 3.02M | |
28-Jun-19 7:07 PM View: | Arcus Biosciences, Inc. (RCUS) | 28-Jun-19 | Market Purchase | 4,894 | $7.89 | $38,636.70 | < 1% 2.96M to 2.97M | 287% |
28-Jun-19 7:07 PM View: | Arcus Biosciences, Inc. (RCUS) | 27-Jun-19 | Market Purchase | 10,106 | $7.44 | $75,216.90 | < 1% 2.95M to 2.96M | 311% |
04-Jun-19 3:44 PM View: | Arcus Biosciences, Inc. (RCUS) | 03-Jun-19 | Market Purchase | 10,000 | $8.25 | $82,485.00 | < 1% 2.94M to 2.95M | 271% |
15-Nov-18 1:21 PM View: | Arcus Biosciences, Inc. (RCUS) | 13-Nov-18 | Purchase | 10,000 | $11.80 | $118,039.00 | < 1% 2.93M to 2.94M | |
13-Aug-18 5:41 PM View: | Arcus Biosciences, Inc. (RCUS) | 13-Aug-18 | Purchase | 3,159 | $11.77 | $37,168.20 | < 1% 2.93M to 2.93M | |
13-Aug-18 5:41 PM View: | Arcus Biosciences, Inc. (RCUS) | 10-Aug-18 | Purchase | 2,579 | $11.94 | $30,796.40 | < 1% 2.93M to 2.93M | |
13-Aug-18 5:41 PM View: | Arcus Biosciences, Inc. (RCUS) | 09-Aug-18 | Purchase | 4,262 | $11.93 | $50,855.50 | < 1% 2.92M to 2.93M | |
19-Mar-18 5:27 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Mar-18 | Conversion | 2,175,150 | -- | -- | 319% 681.82K to 2.86M | |
19-Mar-18 5:27 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Mar-18 | Purchase Duplicate | 66,666 | $15.00 | $999,990.00 | 2% 2.86M to 2.92M | |
11-Mar-13 6:10 PM View: | ChemoCentryx, Inc. (CCXI) | 08-Mar-13 | Market Sale (Planned) | 2,095 | $13.98 | $29,283.70 | (7%) 32.09K to 30.0K | 25% |
11-Mar-13 6:10 PM View: | ChemoCentryx, Inc. (CCXI) | 07-Mar-13 | Market Sale (Planned) | 700 | $13.95 | $9,765.00 | (2%) 32.8K to 32.09K | 25% |
06-Mar-13 7:41 PM View: | ChemoCentryx, Inc. (CCXI) | 06-Mar-13 | Market Sale (Planned) | 4,247 | $13.97 | $59,329.30 | (11%) 37.04K to 32.8K | 25% |
06-Mar-13 7:41 PM View: | ChemoCentryx, Inc. (CCXI) | 05-Mar-13 | Market Sale (Planned) | 2,950 | $13.97 | $41,209.40 | (7%) 39.99K to 37.04K | 25% |
06-Mar-13 7:41 PM View: | ChemoCentryx, Inc. (CCXI) | 04-Mar-13 | Market Sale (Planned) | 5,008 | $13.96 | $69,934.70 | (11%) 45.0K to 39.99K | 25% |
01-Mar-13 7:48 PM View: | ChemoCentryx, Inc. (CCXI) | 28-Feb-13 | Option Exercise | 5,099 | $4.30 | $21,925.70 | 11% 45.0K to 50.1K | |
01-Mar-13 7:48 PM View: | ChemoCentryx, Inc. (CCXI) | 28-Feb-13 | Market Option Sale (Planned) | 5,099 | $13.12 | $66,919.90 | (10%) 50.1K to 45.0K | 21% |
01-Mar-13 7:48 PM View: | ChemoCentryx, Inc. (CCXI) | 27-Feb-13 | Option Exercise | 7,500 | $4.30 | $32,250.00 | 17% 45.0K to 52.5K | |
01-Mar-13 7:48 PM View: | ChemoCentryx, Inc. (CCXI) | 27-Feb-13 | Market Option Sale (Planned) | 7,500 | $12.56 | $94,179.10 | (14%) 52.5K to 45.0K | 17% |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 26-Feb-13 | Option Exercise | 7,500 | $4.30 | $32,250.00 | 17% 45.0K to 52.5K | |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 26-Feb-13 | Market Option Sale (Planned) | 7,500 | $12.37 | $92,756.30 | (14%) 52.5K to 45.0K | 16% |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 25-Feb-13 | Option Exercise | 7,500 | $4.30 | $32,250.00 | 17% 45.0K to 52.5K | |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 25-Feb-13 | Market Option Sale (Planned) | 7,500 | $12.28 | $92,067.40 | (14%) 52.5K to 45.0K | 15% |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 22-Feb-13 | Option Exercise | 7,500 | $4.30 | $32,250.00 | 17% 45.0K to 52.5K | |
26-Feb-13 6:38 PM View: | ChemoCentryx, Inc. (CCXI) | 22-Feb-13 | Market Option Sale (Planned) | 7,500 | $12.05 | $90,382.80 | (14%) 52.5K to 45.0K | 14% |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 21-Feb-13 | Option Exercise | 1,100 | $4.30 | $4,730.00 | 2% 45.0K to 46.1K | |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 21-Feb-13 | Market Sale (Planned) | 1,100 | $11.89 | $13,079.00 | (2%) 46.1K to 45.0K | 12% |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 20-Feb-13 | Option Exercise | 5,601 | $4.30 | $24,084.30 | 12% 45.0K to 50.6K | |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 20-Feb-13 | Market Option Sale (Planned) | 1,100 | $11.90 | $13,086.30 | (2%) 50.6K to 49.5K | 12% |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 20-Feb-13 | Market Sale (Planned) | 4,501 | $11.90 | $53,546.60 | (9%) 49.5K to 45.0K | 12% |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 19-Feb-13 | Option Exercise | 7,500 | $4.30 | $32,250.00 | 14% 53.0K to 60.5K | |
21-Feb-13 7:32 PM View: | ChemoCentryx, Inc. (CCXI) | 19-Feb-13 | Market Option Sale (Planned) | 13,101 | $11.91 | $155,974.00 | (22%) 60.5K to 47.4K | 12% |